vs

Side-by-side financial comparison of DBV Technologies S.A. (DBVT) and VerifyMe, Inc. (VRME). Click either name above to swap in a different company.

VerifyMe, Inc. is the larger business by last-quarter revenue ($5.0M vs $2.8M, roughly 1.8× DBV Technologies S.A.). VerifyMe, Inc. runs the higher net margin — -66.7% vs -1195.5%, a 1128.9% gap on every dollar of revenue. On growth, DBV Technologies S.A. posted the faster year-over-year revenue change (158.8% vs -7.4%). Over the past eight quarters, DBV Technologies S.A.'s revenue compounded faster (12.4% CAGR vs -5.2%).

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

VerifyMe, Inc. is a technology provider specializing in identity verification, anti-counterfeiting, and brand protection solutions. Its offerings include secure authentication tools, supply chain traceability systems, and customer engagement platforms, serving consumer goods, pharmaceutical, and retail sectors across North America and select global markets.

DBVT vs VRME — Head-to-Head

Bigger by revenue
VRME
VRME
1.8× larger
VRME
$5.0M
$2.8M
DBVT
Growing faster (revenue YoY)
DBVT
DBVT
+166.2% gap
DBVT
158.8%
-7.4%
VRME
Higher net margin
VRME
VRME
1128.9% more per $
VRME
-66.7%
-1195.5%
DBVT
Faster 2-yr revenue CAGR
DBVT
DBVT
Annualised
DBVT
12.4%
-5.2%
VRME

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
DBVT
DBVT
VRME
VRME
Revenue
$2.8M
$5.0M
Net Profit
$-33.2M
$-3.4M
Gross Margin
41.2%
Operating Margin
-1235.7%
-68.2%
Net Margin
-1195.5%
-66.7%
Revenue YoY
158.8%
-7.4%
Net Profit YoY
-8.9%
-38.4%
EPS (diluted)
$-0.24
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBVT
DBVT
VRME
VRME
Q3 25
$2.8M
$5.0M
Q2 25
$1.5M
$4.5M
Q1 25
$4.5M
Q3 24
$5.4M
Q2 24
$1.2M
$5.4M
Q1 24
$1.4M
$5.8M
Q4 23
$8.9M
$8.7M
Q3 23
$2.4M
$5.6M
Net Profit
DBVT
DBVT
VRME
VRME
Q3 25
$-33.2M
$-3.4M
Q2 25
$-41.9M
$-291.0K
Q1 25
$-571.0K
Q3 24
$-2.4M
Q2 24
$-33.1M
$-346.0K
Q1 24
$-27.3M
$-553.0K
Q4 23
$134.3M
$2.0K
Q3 23
$-16.7M
$-930.0K
Gross Margin
DBVT
DBVT
VRME
VRME
Q3 25
41.2%
Q2 25
35.2%
Q1 25
33.4%
Q3 24
34.9%
Q2 24
39.1%
Q1 24
39.2%
Q4 23
33.0%
Q3 23
36.5%
Operating Margin
DBVT
DBVT
VRME
VRME
Q3 25
-1235.7%
-68.2%
Q2 25
-2806.2%
-7.1%
Q1 25
-13.3%
Q3 24
-52.8%
Q2 24
-2914.9%
-10.0%
Q1 24
-2029.7%
-11.2%
Q4 23
-134.3%
0.8%
Q3 23
-770.2%
-15.3%
Net Margin
DBVT
DBVT
VRME
VRME
Q3 25
-1195.5%
-66.7%
Q2 25
-2858.4%
-6.4%
Q1 25
-12.8%
Q3 24
-44.6%
Q2 24
-2852.4%
-6.5%
Q1 24
-1943.5%
-9.6%
Q4 23
1512.8%
0.0%
Q3 23
-705.6%
-16.6%
EPS (diluted)
DBVT
DBVT
VRME
VRME
Q3 25
$-0.24
$-0.26
Q2 25
$-0.31
$-0.02
Q1 25
$-0.05
Q3 24
$-0.23
Q2 24
$-0.34
$-0.03
Q1 24
$-0.28
$-0.05
Q4 23
$-0.11
$0.00
Q3 23
$-0.17
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBVT
DBVT
VRME
VRME
Cash + ST InvestmentsLiquidity on hand
$69.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$52.9M
$11.1M
Total Assets
$110.5M
$13.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBVT
DBVT
VRME
VRME
Q3 25
$69.8M
Q2 25
$103.2M
Q1 25
Q3 24
$2.6M
Q2 24
$66.2M
$2.9M
Q1 24
$101.5M
$2.8M
Q4 23
$141.4M
$3.0M
Q3 23
$149.1M
$2.9M
Total Debt
DBVT
DBVT
VRME
VRME
Q3 25
Q2 25
Q1 25
Q3 24
$500.0K
Q2 24
$600.0K
Q1 24
$800.0K
Q4 23
$875.0K
Q3 23
$1.0M
Stockholders' Equity
DBVT
DBVT
VRME
VRME
Q3 25
$52.9M
$11.1M
Q2 25
$86.2M
$14.4M
Q1 25
$14.6M
Q3 24
$10.3M
Q2 24
$79.1M
$12.3M
Q1 24
$111.7M
$12.4M
Q4 23
$140.2M
Q3 23
$144.0M
$11.9M
Total Assets
DBVT
DBVT
VRME
VRME
Q3 25
$110.5M
$13.3M
Q2 25
$143.4M
$17.2M
Q1 25
$17.1M
Q3 24
$14.8M
Q2 24
$114.2M
$17.5M
Q1 24
$145.9M
$17.9M
Q4 23
$183.0M
$20.7M
Q3 23
$189.8M
$18.8M
Debt / Equity
DBVT
DBVT
VRME
VRME
Q3 25
Q2 25
Q1 25
Q3 24
0.05×
Q2 24
0.05×
Q1 24
0.06×
Q4 23
Q3 23
0.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBVT
DBVT
VRME
VRME
Operating Cash FlowLast quarter
$-32.4M
$243.0K
Free Cash FlowOCF − Capex
$-32.6M
FCF MarginFCF / Revenue
-1173.5%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-138.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBVT
DBVT
VRME
VRME
Q3 25
$-32.4M
$243.0K
Q2 25
$-33.9M
$710.0K
Q1 25
$-404.0K
Q3 24
$-10.0K
Q2 24
$-35.1M
$372.0K
Q1 24
$-34.7M
$-60.0K
Q4 23
$-13.7M
$843.0K
Q3 23
$-19.6M
$-136.0K
Free Cash Flow
DBVT
DBVT
VRME
VRME
Q3 25
$-32.6M
Q2 25
$-33.9M
Q1 25
Q3 24
$-12.0K
Q2 24
$-35.8M
$369.0K
Q1 24
$-36.0M
$-62.0K
Q4 23
$-14.0M
$840.0K
Q3 23
$-19.6M
FCF Margin
DBVT
DBVT
VRME
VRME
Q3 25
-1173.5%
Q2 25
-2316.5%
Q1 25
Q3 24
-0.2%
Q2 24
-3084.0%
6.9%
Q1 24
-2560.6%
-1.1%
Q4 23
-158.2%
9.6%
Q3 23
-827.3%
Capex Intensity
DBVT
DBVT
VRME
VRME
Q3 25
4.2%
Q2 25
2.2%
Q1 25
Q3 24
0.0%
Q2 24
63.0%
0.1%
Q1 24
94.9%
0.0%
Q4 23
4.0%
0.0%
Q3 23
2.1%
0.0%
Cash Conversion
DBVT
DBVT
VRME
VRME
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
Q1 24
Q4 23
-0.10×
421.50×
Q3 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DBVT
DBVT

Segment breakdown not available.

VRME
VRME

Proactive Services$4.2M83%
Other$869.0K17%

Related Comparisons